OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 02, 2023
Interoperability difficulties resulting from discrepancies in preferred programming languages can be resolved via statistical computing environments.
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Environmental monitoring data can help keep sterile environments sterile.
July 27, 2023
Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.
Roche will pay up to $2.8 billion for the rights to Alnylam’s RNA-based hypertension therapeutic.
July 24, 2023
Sanofi and Recludix Pharma’s deal centers on developing treatments for various immunological and inflammatory diseases.
July 21, 2023
Under a global license agreement, Bristol Myers Squibb and Evotec will advance the development of neurodegeneration pipeline assets.
The partnership will see Flagship and Pfizer work to create a new pipeline of innovative medicines.
The expanded deal, now potentially worth more than $1.2 billion, will work to develop in vivo therapies, including sickle cell disease.
July 07, 2023
Thermo Fisher Scientific’s new tumoroid culture medium kit is designed to help cancer researchers better model the disease.
Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.